Peer-reviewed veterinary case report
Oclacitinib helps treat a cat's pemphigus foliaceus skin disease
By Carrasco, Isaac et al.·Published in Veterinary dermatology·2021·a Hospital Veterinario Canis, Spain·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Beneficial effect of oclacitinib in a case of feline pemphigus foliaceus.
- Species:
- cat
Plain-English summary
A 5-year-old domestic shorthair cat was diagnosed with pemphigus foliaceus, a serious skin condition that causes painful blisters and sores. The cat was treated with oral oclacitinib, a medication that helps reduce inflammation and immune response. This treatment successfully controlled the cat's symptoms, providing a promising alternative to traditional high-dose steroids. The cat's skin condition improved significantly, leading to a better quality of life.
People also search for: cat skin problems treatment · pemphigus foliaceus in cats · oclacitinib for cats · cat blisters on skin · immune-mediated skin disease in cats
Abstract
Pemphigus foliaceous (PF) is a pustular, immune-mediated skin disease characterised by acantholytic cells and commonly treated with high doses of glucocorticoids. This report describes one case of feline PF successfully controlled using oral oclacitinib, suggesting a possible therapeutic alternative to glucocorticoids in some cases.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33720467/